| 产品描述: | CX-6258 hydrochloride is a potent and kinase selective pan-Pim kinases inhibitor, with IC50s of 5 nM, 25 nM and 16 nM for Pim-1, Pim-2 and Pim-3, respectively |
| 靶点: |
IC50: 5 nM (Pim-1), 25 nM (Pim-2), 16 nM (Pim-3);Pim |
| 体外研究: |
CX-6258 hydrochloride 分别在 Pim 激酶特异性位点 S112 和 S65 以及 T37/46 引起剂量依赖性抑制两种促存活蛋白 Bad 和 4E-BP1 的磷酸化。 CX-6258 hydrochloride 处理 (12 mM,3 小时) 处理降低了 PC3 细胞中异位 NKX3.1 的稳态水平。 CX-6258 hydrochloride 处理导致 NKX3.1 半衰期显著缩短。 Western Blot Analysis Cell Line: MV-4-11 human AML cells. Concentration: 0.1 μM, 1 μM, 10 μM. Incubation Time: 2 hours. Result: Caused dose dependent inhibition of the phosphorylation of two pro-survival proteins, Bad and 4E-BP1, at the Pim kinase specific sites S112 and S65 and T37/46, respectively. |
| 体内研究: |
CX-6258 hydrochloride (50-100 mg/kg;口服;每日一次;为期 21 天) 在两种 Pim 激酶驱动的肿瘤模型中表现出强大的体内功效。 Animal Model: Nude mice, MV-4-11 xenograft models Dosage: 50 mg/kg, 100 mg/kg. Administration: Oral administration; once daily; over a period of 21 days. Result: Exhibitd dose dependent efficacy, with a 50 mg/kg dose producing 45% tumor growth inhibition (TGI) and a 100 mg/kg dose producing 75% TGI. |
| 参考文献: |
1. Mustapha Haddach, Jerome Michaux, Michael K, Discovery of CX-6258. A Potent, Selective, and Orally Efficacious pan-Pim Kinases Inhibitor. ACS Med. Chem. Lett., 2012, 3 (2), pp 135-139. 2. Padmanabhan A, Gosc EB, Bieberich CJ. Stabilization of the prostate-specific tumor suppressor NKX3.1 by the oncogenic protein kinase Pim-1 in prostate cancer cells. J Cell Biochem. 2013 May;114(5):1050-7. |
| 溶解性: |
Soluble in DMSO、H2O |
| 保存条件: |
-20°C |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.006 ml |
10.032 ml |
20.064 ml |
| 5 mM |
0.401 ml |
2.006 ml |
4.013 ml |
| 10 mM |
0.201 ml |
1.003 ml |
2.006 ml |
| 50 mM |
0.04 ml |
0.201 ml |
0.401 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |